🔎 Trials Near Me

Почетна › Метастатски карцином › Minesota › Rochester

Kliničke studije za Метастатски карцином u gradu Rochester, MN

28 studija za Метастатски карцином traži učesnike na lokacijama u gradu Rochester i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.

Zvanični tekst studije (na engleskom)

Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

Testing the Combination of DS-8201a and Olaparib in HER2-Expressing Cancers With Expansion in Patients With Platinum Resistant Ovarian Cancer

Тражи се учесникФаза 1
  • Mayo Clinic in Rochester, Rochester
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT04585958

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

Тражи се учесникФаза 2
  • Mayo Clinic in Rochester, Rochester
Сви узрасти · Оба пола · Ажурирано 12. 11. 2026. · NCT05564377

Highly Selective CDK7 Inhibitor Q901 in Selected Advanced Solid Tumors

Тражи се учесникФаза 1/2
  • Mayo Clinic, Rochester
Узраст 18 и старији · Оба пола · Ажурирано 9. 11. 2026. · NCT05394103

ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer

Тражи се учесникФаза 2
  • Mayo Clinic Cancer Center, Rochester
Узраст 18 и старији · Оба пола · Ажурирано 9. 11. 2026. · NCT07007559

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Тражи се учесникФаза 3
  • Mayo Clinic in Rochester, Minnesota, Rochester
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07174336

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

Тражи се учесникФаза 3
  • Mayo Clinic in Rochester, Minnesota, Rochester
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07213804

Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors

Тражи се учесникФаза 2/3
  • Mayo Clinic, Rochester
Узраст 18 и старији · Оба пола · Ажурирано 30. 10. 2026. · NCT06943755

Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 or 2 Systemic Treatment Regimens

Тражи се учесникФаза 3
  • Mayo Clinic - Rochester, Mn, Rochester
Узраст 18 и старији · Оба пола · Ажурирано 28. 10. 2026. · NCT06127407

Adding Spatially Fractionated Radiation Therapy to Standard Palliative Radiation for Improving Disease-Related Symptoms in Patients With Unresectable Solid Tumors

Тражи се учесник
  • Mayo Clinic in Rochester, Rochester
Узраст 15 и старији · Оба пола · Ажурирано 26. 10. 2026. · NCT07856394

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

Тражи се учесникФаза 1/2
  • Mayo Clinic (Minnesota), Rochester
Узраст 18 и старији · Оба пола · Ажурирано 22. 10. 2026. · NCT04657068

A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)

Тражи се учесникФаза 1
  • Mayo Clinic, Rochester
Узраст 18 и старији · Мушкарци · Ажурирано 20. 10. 2026. · NCT07103018

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

Тражи се учесникФаза 2/3
  • Mayo Clinic Cancer Center Outpatient Pharmacy, Rochester
  • Mayo Clinic, Rochester
Узраст 18 и старији · Оба пола · Ажурирано 14. 10. 2026. · NCT06989437

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

Тражи се учесникФаза 1/2
  • Mayo Clinic Hospital, Methodist Campus, Research Pharmacy, Rochester
  • Mayo Clinic Cancer Center Outpatient Pharmacy, Rochester
Узраст 18 и старији · Оба пола · Ажурирано 8. 10. 2026. · NCT07227415

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

Тражи се учесникФаза 3
  • Mayo Clinic Hospital, Methodist Campus, Research Pharmacy, Rochester
  • Mayo Clinic Pharmacy, Rochester
  • Mayo Clinic Cancer Center Outpatient Pharmacy, Rochester
  • и још 3
Узраст 18 и старији · Оба пола · Ажурирано 8. 10. 2026. · NCT07222800

FOG-001 in Locally Advanced or Metastatic Solid Tumors

Тражи се учесникФаза 1/2
  • Mayo Clinic, Rochester
Узраст 18 и старији · Оба пола · Ажурирано 7. 10. 2026. · NCT05919264

SRS Compared With FSRS for Treatment of Intact Metastatic Brain Disease, FRACTIONATE Trial

Тражи се учесникФаза 2
  • Mayo Clinic in Rochester, Rochester
Узраст 18 и старији · Оба пола · Ажурирано 1. 10. 2026. · NCT05222620

PRE-ISPY Phase I/II Oncology Platform Program

Тражи се учесникФаза 1/2
  • Mayo Clinic Comprehensive Cancer Center, Rochester
Узраст 18 и старији · Оба пола · Ажурирано 30. 9. 2026. · NCT05868226

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

Тражи се учесникФаза 1
  • Mayo Clinic Rochester, Rochester
Узраст 18 и старији · Оба пола · Ажурирано 28. 9. 2026. · NCT07277413

A Study of Nuzefatide Pevedotin (BT5528) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)

Тражи се учесникФаза 2
  • Mayo Clinic Rochester, Rochester
Узраст 18 и старији · Оба пола · Ажурирано 18. 9. 2026. · NCT07450859

A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors

Тражи се учесникФаза 1
  • Mayo Clinic - Rochester, Rochester
Узраст 18 и старији · Оба пола · Ажурирано 2. 9. 2026. · NCT04913285

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

Тражи се учесникФаза 3
  • Mayo Clinic-Comprehensive Cancer Center-Breast Clinic, Rochester
Узраст 18 и старији · Оба пола · Ажурирано 2. 9. 2026. · NCT06072612

Evaluation of Anti-PD-1 Therapy by Monitoring T Cell Responses in Melanoma, Lung and Other Cancer Types

Тражи се учесникОпсервациона студија
  • Mayo Clinic in Rochester, Rochester
Узраст 18 и старији · Оба пола · Ажурирано 18. 6. 2026. · NCT06075524

Examining Blood and Tissue Samples to Identify Diagnostic Markers in Patients With Metastatic Cancer Undergoing Tumor Removal

Тражи се учесникОпсервациона студија
  • Mayo Clinic in Rochester, Rochester
Узраст 18 и старији · Оба пола · Ажурирано 9. 6. 2026. · NCT05530759

Group Cognitive Behavior Sessions (CBCSM) to Decrease Distress in Cancer Patients

Тражи се учесник
  • Mayo Clinic in Rochester, Rochester
Узраст 18 и старији · Оба пола · Ажурирано 9. 6. 2026. · NCT06015932

Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma

Тражи се учесникФаза 2/3
  • Mayo Clinic Comprehensive Cancer Center, Rochester
Узраст 18 и старији · Оба пола · Ажурирано 17. 4. 2026. · NCT06947928

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

Тражи се учесникФаза 2/3
  • Mayo Clinic Rochester, Rochester
Сви узрасти · Оба пола · Ажурирано 2. 4. 2026. · NCT06581406

Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform

Тражи се учесникОпсервациона студија
  • Mayo Clinic in Rochester, Rochester
Узраст 18 и старији · Оба пола · Ажурирано 12. 3. 2026. · NCT06349642

A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)

Тражи се учесникФаза 1/2
  • Mayo Clinic in Minnesota, Rochester
Узраст 18 и старији · Оба пола · Ажурирано 25. 11. 2024. · NCT05824975

Studije za Метастатски карцином u drugim gradovima

Ostale studije u gradu Rochester

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.